Welcome to vpod.ai’s The Deep Dive, proudly sponsored by StoneFly. In this episode, we explore the complex, often misunderstood world of neuroendocrine tumors (NETs)—from silent symptoms to cutting-edge treatments revolutionizing outcomes.

You'll learn:

• What NETs are, where they originate, and why the term “carcinoid” is outdated
• How carcinoid syndrome causes symptoms like flushing, diarrhea, and heart issues
• The step-by-step diagnostic process, from biomarkers to biopsy
• Why surgery remains vital—and what’s next when surgery isn’t enough
• Advances in somatostatin analogs, Everolimus, and targeted therapies
• Game-changers like CAR-T cell therapy, new immunotherapy combinations, and anti-angiogenesis drugs
• How the latest FDA approvals are reshaping care for advanced and aggressive NETs

This is the frontline of rare cancer research—where collaboration, innovation, and precision medicine are making a real difference.